Yaz Lawsuits

 

Yaz Lawsuits

Multiple lawsuits brought against Bayer HealthCare Pharmaceutical over the birth control drugs Yaz and Yasmin, and against Barr Laboratories for the generic form of the drug called Ocella, have been combined in a class action suit. The Judicial Panel on Multi-District Litigation has assigned all Federal court cases to US District Court Four of southern Illinois.

Yaz, the top selling birth control pill in the United States, and Yasmin, one of the most popular drugs of their line, are manufactured and marketed by Bayer HealthCare. Ocella is manufactured by Bayer, and is then packaged and sold by Barr Laboratories, newly acquired by Teva Pharmaceuticals.

All three of these birth control pills contain a synthetic version of the hormone progestin called drospirenone. With the addition of ethinyl estradiol, or estrogen, the combination acts to prevent pregnancy. The use of Drospirenone in birth control drugs is exclusive to Bayer .

Drospirenone is believed to be the major factor that causes side effects in Yaz, Yasmin, which contains less estrogen, and Ocella. These side effects can include heart attack, stroke, deep vein thrombosis, pulmonary embolism, blood clots in legs and lungs, cardiac arrhythmia, gall bladder disease, kidney failure, and sudden death.

The British Medical Journal published two recent case-control studies that showed patients using Drospirenone-containing oral contraception are 200% more likely to have a higher risk of side effects than those patients using other birth control pills not containing the synthetic hormone.

Recently, the New York Times also published a major news story regarding the growing safety concerns with Yaz, Yasmin, and Ocella. These top selling drugs owe much of their popularity to a multi-million dollar advertising campaign touting them as much more than just pregnancy prevention. They promoted the drugs as a "quality of life" treatment to clear up acne and relieve severe premenstrual depression. They were also successfully marketed to the "under 35" demographic as the birth control pill of choice. The franchise gained worldwide sales of 1.8 billion dollars last year.

Yaz, Yasmin, and Ocella's luster began to fade as researchers, women's health advocates, plaintiff's lawyers, and Yaz Attorneys' allegations regarding the birth control pills began to emerge. Women are put at higher risk for blood clots, strokes, and other health problems when taking Yaz, Yasmin, and Ocella, than with other oral contraceptives.

Germany's Bayer HealthCare answered with its own sponsored European Health Study. It reported that Yaz, Yasmin, and Ocella put women at no greater risk for cardiovascular complications than the older birth control pills.

However, the Yaz franchise are having other American problems. The FDA early this year directed Bayer to clarify some of it's earlier commercials that were found to be misleading, suggesting that drospirenone is "chemically superior" to other oral contraceptives when it is not. The FDA also cited the company, finding that proper quality control procedures were not being followed in a facility that makes the hormone ingredients.

Bayer states that the company has been served with seventy four lawsuits to date. The lawsuits are brought by women who charge that after they began to take Yaz or Yasmin they began to experience health problems.

It has long been known that birth control pills work by altering the hormones in a woman's body. Research shows that taking a combination oral contraceptive including estrogen and progestin can increase the risk of stroke and blood clots localized in the legs and lungs, as estrogen can play a role in blood coagulation.

This reportage, and much more, will be utilized by the "Yaz Attorneys" in their efforts to secure justice for their Yaz, Yasmin, and Ocella Plaintiffs. They certainly have their work cut out for them.

Yaz Stroke

Yaz Blood Clots

Yaz Lawsuits